10 Feb 2009

UCB sells anti-haemorrhagic drug to Eumedica

Read More
6 Feb 2009

UCB's meeting with U.S. FDA defines path forward for Cimzia® in rheumatoid arthritis.

Read More
23 Jan 2009

UCB to divest selected smaller markets to further focus on its key strategic areas

Read More
9 Jan 2009

UCB and WILEX to enter into strategic alliance to develop UCB's preclinical oncology portfolio

Read More
5 Jan 2009

UCB receives Complete Response Letter from U.S. FDA for use of Cimzia® in rheumatoid arthritis patients

Read More
19 Dec 2008

UCB receives U.S. FDA Complete Response Letter for Neupro® in Restless Legs Syndrome and Advanced Parkinson's disease

Read More
2 Dec 2008

UCB announces start of Phase I study for antibody drug candidate CDP6038

Read More
20 Nov 2008

Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate in Fibromyalgia

Read More
18 Nov 2008

Cimzia® studies show significant clinical benefits for mono- and combination therapy in patients with rheumatoid arthritis

Read More
31 Oct 2008

Transparency Notification Of UCB's Reference Shareholders

Read More
Subscribe to